Monday, January 23, 2017 9:29:31 PM
If there were only "the product" as you put it (actually three - loop, heel and allay) they wouldn't need to do more R&D.
IMHO a number of new products coming but not going to "launch" as that takes cash.
higher powered RecoveryRx for BBraun is one item, deeper penetrating one for internal surgery recovery another. BPH one may need special mechanism for looping/attaching.
So BIEL is not a one trick pony when considering value to a pharma buyout.
I am certain there will be bids once FDA clearance is given but will Andy sell?
I suspect an offer over 5c will be attractive.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM